Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromesMaría‐Teresa Cedena, Joaquín Martínez‐López, Esperanza Such et al.|Oncotarget|2017Cited by 43
Mutations in DNA Methylation Pathway and Number of Driver Mutations Predict Response to Azacitidine in Myelodysplastic SyndromesMaría‐Teresa Cedena, Joaquín Martínez‐López, Inmaculada Rapado et al.|Leukemia Research|2017Cited by 6
Correction: Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromesMaría‐Teresa Cedena, Joaquín Martínez‐López, Inmaculada Rapado et al.|Oncotarget|2018Cited by 1